(Q34235801)

31 July 2017

1 reference

title

Axonal Guillain-Barré syndrome: a critical review (English)

1 reference

31 July 2017

main subject

Guillain–Barré syndrome

0 references

author name string

Chowdhury D

series ordinal

1

1 reference

31 July 2017

Arora A

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Acta Neurologica Scandinavica

31 July 2017

published in

1 reference

31 July 2017

volume

103

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

267-277

1 reference

Assessment of current diagnostic criteria for Guillain-Barré syndrome

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

An acute axonal form of Guillain-Barré polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Axonal degeneration in demyelinating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Acute polyradiculitis (Guillain-Barr� syndrome): An epidemiological study of 156 cases observed in beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Guillain-Barre syndrome in Korean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

21 January 2018

Acute paralytic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Campylobacter Diarrhea and Guillain-Barre Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Anti-GM1/GD1b M-proteins damage human spinal cord neurons co-cultured with muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Relation between critical illness polyneuropathy and axonal Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Plasmapheresis with acute inflammatory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Severe Guillain-Barré syndrome in childhood treated with human immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Pathology of the motor-sensory axonal Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Patterns of recovery in the Guillain-Barre syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

Pathology of the Guillain-Barr� syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Conduction block and denervation in Guillain-Barré polyneuropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Acute axonal idiopathic polyneuropathy: a Guillain-Barré syndrome variant?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Motor nerve biopsy in severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Acute motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autopsied cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Campylobacter jejuni and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Guillain-Barré syndrome and Campylobacter jejuni: a serological study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Activity-dependent hyperpolarization of human motor axons produced by natural activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Pathogenesis of axonal Guillain-Barré syndrome: hypothesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Motor neuron reactivity of sera from animals with autoimmune models of motor neuron destruction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

HLA-B35 and acute axonal polyneuropathy following Campylobacter infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005267.X

7 January 2021

10.1034/J.1600-0404.2001.103005267.X

Identifiers

DOI

1 reference

31 July 2017

1 reference